Regen BioPharma (RGBP) Stock Resumes Rally After a Day Break: Now What?

If you are fond of penny stocks, then you must have heard of Regen BioPharma Inc (OTCMKTS: RGBP). The stock has been getting a lot of attention this week after announcing a licensing deal for its pancreatic cancer treatment.

Just after the news, within 3 sessions the stock went up as cosmic as 3800% on huge volume. However, On Tuesday, the stock ended lower for the first time in four trading sessions. However, on Wednesday, the stock resumed its rally and went up over 22% on the massive volume of over 1 billion shares, which amounts to $46 million in dollar volume.

Related:  Ocugen (OCGN) Consolidates Below $10: A Good Buy Now?

Going forward, considering the news and daily big move, penny stock traders must expect a lot of volatility in the stock. Moreover, the stock made a new 52-week high of $0.0819 on Tuesday. So one needs to watch out for the stock if it crosses the recent highs as this could be a new breakout. But, one should trade cautiously as we all know penny stocks are king when it comes to volatility.

Jack Dawkins

Finance and Tech Contributor